Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

From science-backed supplements to insurance-covered nutrition therapy, here's your complete guide to effective weight loss ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...